The Role That Oncotarget Plays In The Medical Research Community

Oncotarget is an online medical journal that was first published by Impact Journals, LLC in 2010. It has become very popular as it publishes the latest medical research on a weekly basis as well as being open access. Oncotarget was co-founded by Andrei V. Gudkov and Mikhail Blagosklonny who both work at the Roswell Park Cancer Institute in Buffalo, New York. They are also the co-editors-in-chief of Oncotarget. Follow Oncotarget on Twitter.

For the first six years of Oncotarget’s life it was focused on Oncology, the area of medicine that both Blagosklonny and Gudkov have their Doctorates in. In 2017 the medical journal became a multidisciplinary journal by beginning to publish research in other fields like Metabolism, Cardiology, Endocrinology, and other areas. This helps to fulfill one of Oncotarget’s goals which is to bring down the walls that exist between different medical disciplines which will foster deeper and more comprehensive research. They also want to make the latest in medical research broadly and quickly available which is why they publish weekly. The ultimate goal of the people behind Oncotarget is playing a part in ending disease.

The research papers that are published in Oncotarget are often cited by other researchers. This has led to this medical journal having a very high impact factor as measured by Journal Citation Reports. One recent and highly cited research paper was about the health effects of e-cigarettes which have grown highly popular over the last several years. While many people think they’re safer than conventional cigarettes as it turns out they too cause a host of diseases and health problems according to the research. Visit his profile on Google Scholar.

In the last four years, four members of Oncotarget and its sister publications Oncoscience and Gerotarget have won the prestigious industry award named Breakthrough Prize. These four are Stephen J. Elledge, Alexander Varshavsky, Bert Vogelstein, and Michael N. Hall. Furthermore, Oncotarget is a sponsor of the highly anticipated Gordon Research Conference which will be taking place July 9-14, 2017 at the University of New England in Biddeford, ME.

Leave a Reply

Your email address will not be published. Required fields are marked *